These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 235610)

  • 1. Some pharmacological actions of 2,5-dimethoxy-4-ethylamphetamine (DOET) in rats and mice.
    Huang J; Ho BT
    J Pharm Pharmacol; 1975 Jan; 27(1):18-22. PubMed ID: 235610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific actions of 2,5-dimethoxy-4-methylamphetamine (DOM) on colonic temperature in the rat at various ambient temperatures.
    Beaton JM; Benington F; Bradley RJ; Kuhlemeier KV; Morin RD
    Br J Pharmacol; 1976 Aug; 57(4):547-50. PubMed ID: 134754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice.
    Yamamoto T; Ueki S
    Eur J Pharmacol; 1975; 32(02):156-62. PubMed ID: 1149803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pressor action of 2,5-dimethoxy-4-methylamphetamine in rats.
    Huang J; Beng TH
    J Pharm Pharmacol; 1972 Aug; 24(8):656-7. PubMed ID: 4403750
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
    Shimamine M; Takahashi K; Nakahara Y
    Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic study of 2,5-dimethoxy-4-ethylamphetamine (DOET) in rats.
    Tansey LW; Estevez VS; Ho BT
    Proc West Pharmacol Soc; 1975; 18():362. PubMed ID: 1182040
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
    Tilson HA; Baker TG; Chamberlain JH
    Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 11. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
    Jacob P; Shulgin AT
    J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the behavioral effects of DOM homologs.
    Glennon RA; Young R; Rosecrans JA
    Pharmacol Biochem Behav; 1982 Apr; 16(4):557-9. PubMed ID: 7071089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOM and related 2,5-dimethoxy-4-alkylphenylisopropylamines: behavioral and serotonin receptor properties.
    Glennon RA; Doot DL; Young R
    Pharmacol Biochem Behav; 1981 Mar; 14(3):287-92. PubMed ID: 7232455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of monoamine oxidase inhibitors on the cardiovascular action of some analgesics.
    Jounela AJ
    Ann Med Exp Biol Fenn; 1970; 48(4):249-60. PubMed ID: 5492145
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 2, 5-dimethoxy-4-methylamphetamine (DOM, STP) on successive sensory discrimination behavior maintained by electrical stimulation of the brain reinforcement in the rat.
    Vincent JH; Lenzer II
    Psychol Rep; 1976 Jun; 38(3 Pt 2):1083-92. PubMed ID: 935303
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
    Aulakh CS; Mazzola-Pomietto P; Wozniak KM; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1994 Jul; 270(1):127-32. PubMed ID: 8035308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
    Tilson HA; Chamberlain JH; Gylys JA
    Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chirality on serotonin receptor affinity.
    Glennon RA
    Life Sci; 1979 Apr; 24(16):1487-92. PubMed ID: 470548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.